Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Saved in:
| Title: | Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures. |
|---|---|
| Authors: | Spigel, David R.1,2 dspigel@tnonc.com, Burris, Howard A.1,2, Greco, F. Anthony1,2, Shih, Kent C.1,2, Gian, Victor G.1,2, Lipman, Andrew J.1,3, Daniel, Davey B.1,4, Waterhouse, David M.5, Finney, Lindsey1, Heymach, John V.6, Hainsworth, John D.1,2, Burris, Howard A 3rd7,8 (AUTHOR) |
| Source: | Cancer (0008543X). Jun2018, Vol. 124 Issue 11, p2355-2364. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 129838400 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Spigel%2C+David+R%2E%22">Spigel, David R.</searchLink><relatesTo>1,2</relatesTo><i> dspigel@tnonc.com</i><br /><searchLink fieldCode="AR" term="%22Burris%2C+Howard+A%2E%22">Burris, Howard A.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Greco%2C+F%2E+Anthony%22">Greco, F. Anthony</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Shih%2C+Kent+C%2E%22">Shih, Kent C.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Gian%2C+Victor+G%2E%22">Gian, Victor G.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Lipman%2C+Andrew+J%2E%22">Lipman, Andrew J.</searchLink><relatesTo>1,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Daniel%2C+Davey+B%2E%22">Daniel, Davey B.</searchLink><relatesTo>1,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Waterhouse%2C+David+M%2E%22">Waterhouse, David M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Finney%2C+Lindsey%22">Finney, Lindsey</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Heymach%2C+John+V%2E%22">Heymach, John V.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Hainsworth%2C+John+D%2E%22">Hainsworth, John D.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Burris%2C+Howard+A+3rd%22">Burris, Howard A 3rd</searchLink><relatesTo>7,8</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+%280008543X%29%22">Cancer (0008543X)</searchLink>. Jun2018, Vol. 124 Issue 11, p2355-2364. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=129838400 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.31290 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 2355 Titles: – TitleFull: Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spigel, David R. – PersonEntity: Name: NameFull: Burris, Howard A. – PersonEntity: Name: NameFull: Greco, F. Anthony – PersonEntity: Name: NameFull: Shih, Kent C. – PersonEntity: Name: NameFull: Gian, Victor G. – PersonEntity: Name: NameFull: Lipman, Andrew J. – PersonEntity: Name: NameFull: Daniel, Davey B. – PersonEntity: Name: NameFull: Waterhouse, David M. – PersonEntity: Name: NameFull: Finney, Lindsey – PersonEntity: Name: NameFull: Heymach, John V. – PersonEntity: Name: NameFull: Hainsworth, John D. – PersonEntity: Name: NameFull: Burris, Howard A 3rd IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2018 Type: published Y: 2018 Identifiers: – Type: issn-print Value: 0008543X Numbering: – Type: volume Value: 124 – Type: issue Value: 11 Titles: – TitleFull: Cancer (0008543X) Type: main |
| ResultId | 1 |